Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus dexmedetomidine gargle for prevention of postoperative sore throat
IRCT20181126041760N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ketamine and dexmedetomidine in Post-extubation sore throat (POST), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Postoperative sore throat severity and Postoperative dry throat. Started Feb 2019; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on IRCT20181126041760N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181126041760N2.